Glioblastoma, the most malignant primary glial brain tumor, is challenging to cure. Its progression involves profound changes in the tumor microenvironment that includes extensive remodeling of the extracellular matrix (ECM). However, the impact of ECM fiber tension on cell-ECM crosstalk during brain tumor progression has not been explored. To address this, a thoroughly validated peptide tension probe (FnBPA5) is used to stain tissue cryosections and assess fibronectin fiber tension. It is found that in the infiltration zone, microvascular proliferations (MVPs) are filled with low-tension fibronectin fibers alongside layered endothelial cells and alpha-smooth muscle actin (α-SMA) expressing cells, in contrast to microvessels (MVs). Also brain tissue areas infiltrated by immune cells-specifically, CD45+/CD68+ macrophages-contained abundant untensed fibronectin fibers. Occasionally, leukocytes formed non-encapsulated CD45+ aggregates that partially co-localized with lymphatic-endothelial-like cells (LEC-like). Significantly, the number of leukocytes is directly proportional to the density of collagen I/III fibers. These CD45+ aggregates have morphological similarities with Tertiary Lymphoid Structures (TLS). The discovery that fibronectin fibers lose their tension in MVPs and in immune cell-infiltrated parenchyma is significant as ECM fiber tension is known to mechano-tune molecular interactions. The findings introduce the potential for novel therapeutic strategies that exploit ECM mechanics to improve glioblastoma treatment outcomes.
Loss of Fibronectin Fiber Tension in Glioblastoma is Associated with Microvascular Proliferations and Immune Cell Infiltration.
阅读:3
作者:Crestani Michele, Gerber Isabel, Mieville Arnaud, Frauenknecht Katrin, Maragkou Theoni, Hortobagyi Tibor, Vogel Viola
| 期刊: | Advanced Science | 影响因子: | 14.100 |
| 时间: | 2025 | 起止号: | 2025 Dec;12(45):e16526 |
| doi: | 10.1002/advs.202416526 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
